Nerai Bio is advancing the frontier of genome editing with a new generation of ultra-precise CRISPR enzymes engineered to unlock genomic targets beyond the reach of existing technologies. Our proprietary MORPHEME platform combines AI and high-throughput protein engineering via directed evolution to design bespoke genome editors with unmatched specificity and therapeutic potential. Our mission is to create a world where no genetic disease is too rare, too hard, or too complex to cure. At Nerai, we don’t just edit DNA—we aim to rewrite the future of patients.
Company Details
- Employees
- 6
- Address
- Dorfstrasse, Zurich,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.nerai.bio/
- HQ
- Zurich
Nerai Bioscience Questions
Nerai Bioscience's website is https://www.nerai.bio/
Nerai Bioscience's LinkedIn profile is https://ch.linkedin.com/company/nerai-bio
Nerai Bioscience has
6 employees.
View email and phone details for 6
employees at Nerai Bioscience.
Nerai Bioscience's industry is
Biotechnology Research
Nerai Bioscience's top competitors are
Abrinca Genomics,
Invirtuolabs,
Alp Ai,
Inkvivo Technologies Ag,
Mynerva Ag,
Aukera Therapeutics,
Amporin Pharmaceuticals,
Hemostod,
Juvion Health Sciences,
Apricot Bio.
Nerai Bioscience's categories are Biotechnology Research
